Healthier Choices Management (HCMC) news for Wednesday includes shares of the stock skyrocketing on lawsuit speculation from Reddit. The company announced some good news regarding one of its COVID-19 programs. News explorer – Search Regulatory news, RNS Search, via Company or code, Index, Industry Sector, Headline type, Release date and Source

Home / Today’s Market / Healthier Choices Management News: HCMC Stock Skyrockets Amid Lawsuit Speculation

Healthier Choices Management (OTCMKTS:HCMC) news for Wednesday includes shares of the stock skyrocketing on lawsuit speculation.

To go with this is an increase in trading for HCMC stock. As of this writing, the company has seen more than 3 billion shares change hands. That’s a massive increase next to its daily average trading volume of about 356 million shares.

Here’s everything that investors need to know as shares of HCMC stock head higher.

Healthier Choices Management is suing Philip Morris International (NYSE:PM) over patent infringement.

The lawsuit was originally filed back in November 2020, but is picking up steam again thanks to a post on Reddit Pennystocks.

This has investors taking interest in the company as they speculate it could win the lawsuit against PM.

If so, the company is seeking damages from Philip Morris International.

The lawsuit alleges that PM infringed on its patent 170 with its IQOS tobacco vapor product.

Healthier Choices Management is a company that focuses on providing customers with healthier lifestyle options.

It operates an 18,000 sq. ft. grocery store in Fort Myers, Fla., as well as three Paradise Health & Nutrition locations in the greater Melbourne, Fla., area.

However, it’s likely its other business that has it battling Philip Morris International.

The company operates nine vape shops throughout the shoueast U.S.

It does so through various names, such as The Vape Store, Vapor Max, Vulcan Vape, and The Grab Bag.

It also owns several patents in connection to electronic cigarettes.

HCMC is lead by chairman and CEO Jeffrey Holman, who previously served on the Board of Directors for its Smoke Anywhere USA subsidiary.

HCMC stock was up 66.7% as of Wednesday afternoon.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Article printed from InvestorPlace Media, https://investorplace.com/2021/01/healthier-choices-management-news-hcmc-stock-skyrockets-amid-lawsuit-speculation/.

Source: investorplace.com

Author: By

William White, InvestorPlace Writer

Why Vir Biotechnology Stock Is Skyrocketing Today

Shares of Vir Biotechnology (NASDAQ:VIR) are soaring through the roof on Wednesday following the company’s announcement of the start of a clinical trial to evaluate one of its pipeline candidates as part of a potential combination therapy for COVID-19. As of 1:29 p.m. EST, shares of the biotech are up by 32.5%, after rising by as much as 79% earlier today.

Vir Biotechnology is developing VIR-7831 in collaboration with GlaxoSmithKline (NYSE:GSK). Today, the two drugmakers announced the dosing of the first patient in a clinical trial to assess the efficacy of the combination of VIR-7831 and Eli Lilly’s (NYSE:LLY) bamlanivimab in low-risk patients with mild to moderate COVID-19. Eli Lilly originally kicked off a phase 2 clinical trial for bamlanivimab last year.

But the pharma giant is looking to experiment bamlanivimab with other therapies to find effective treatments for all current and future strains of the disease. That is why it decided to expand its ongoing study and team up with Vir Biotechnology and GlaxoSmithKline to test whether the combination of bamlanivimab and VIR-7831 could be an effective treatment.

Face mask with "COVID-19" written on it.

Image source: Getty Images.

Given that Vir Biotechnology is a much smaller company (in terms of market cap) than the other two, it makes sense that the biotech’s stock is the only one of the three that is skyrocketing today.

Vir Biotechnology has already more than doubled this year, and there could be more gains on the horizon for the company if its COVID-19 treatment and other programs pan out. Investors would do well to keep an eye on this biotech.

Source: www.fool.com

Author: Prosper Junior Bakiny

News by BANKERS INVESTMENT TRUST PLC Company or code – between 28 October 2020 and 28 January 2021 Time period News explorer

News Explorer

Clear filters

Apply filters

Company or code matches BANKERS INVESTMENT TRUST PLC

Time period matches between 28 October 2020 and 28 January 2021

Sort by

Sort by most recent

RNS

22 January 2021